Author:
Kinoshita Ryo,Miyamoto Sho,Sakuraba Shoko,Sugihara Jun,Suzuki Motoi,Suzuki Tadaki,Yoneoka Daisuke
Publisher
Centers for Disease Control and Prevention (CDC)
Reference15 articles.
1. National seroepidemiological study of COVID-19 after the initial rollout of vaccines: Before and at the peak of the Omicron-dominant period in Japan.;Arashiro;Influenza Other Respir Viruses,2023
2. Ministry of Health, Labour, and Welfare of Japan. Health Center Real-time Information-sharing System (HER-SYS). 2023 [cited 2023 Oct 12]. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00129.html
3. Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022.;Wiegand;Lancet Reg Health Am,2023
4. Ministry of Health, Labour, and Welfare of Japan. Seroprevalence of SARS-CoV-2. 2023 [cited 2023 Oct 12]. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00132.html
5. Infection-induced SARS-CoV-2 seroprevalence among blood donors, Japan, 2022.;Kinoshita;Emerg Infect Dis,2023